Appili Therapeutics to be acquired by Virginia-based life sciences company Aditxt
Deal is contingent upon Aditxt raising at least $20 million USD.
Deal is contingent upon Aditxt raising at least $20 million USD.
Plus: Neuralink is now accepting Canadian patients.
Plus: Neuralinkâs first human subject shows off abilities on livestream.
Province hints that the OSC is developing new rules to support angel investors.
Deal is hoped to strengthen Dialogueâs support for womenâs healthcare.
Plus: Healthcare startup Tempus preps for IPO.
AstraZeneca says the deal marks âa major step forwardâ in its goal to transform cancer treatment.
The regional development agency is doling out nearly $14 million.
Startupâs FloPatch product measures blood flow for critically ill patients.
Startup adds Round13, Deloitte, Samsung to fuel efforts to help patients understand their medical images.
Plus: Vancouver looks to join the global big leagues of modern medicine.
Pre-clinical startup discovers drugs that treat inflammatory diseases.
Plus: Myanmar Molecular seeks Health Canada approval.
MedReddie, SkyAcres, and Nimble Science represent Canada in the class of 2024.
Cognito plans to expand its mental health services across Canada this year.